Poster: CLL-118 A Phase 1 Study With the Novel B-Cell Lymphoma 2 Inhibitor BGB-11417 as Monotherapy or in Combination With Zanubrutinib in Patients With B-Cell Malignancies: Preliminary Data

Authors :: Jacob D. Soumerai
Stephen Opat
Chan Y. Cheah
Masa Lasica
Emma Verner
Peter J. Browett
Henry Chan
Eva González Barca
James Hilger
Yiqian Fang
David Simpson
Constantine S. Tam
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S140
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools